Insights from 2024 ASCO® GU Annual Meeting


 

ASCO® GU 2024 Insights: "Subcutaneous vs. Intravenous Nivo for Previously Treated Advanced or Metastatic ccRCC: Pharmacokinetics, Efficacy, and Safety Results From CheckMate 67T"

115 views
February 20, 2024
Comments 0
Login to view comments. Click here to Login